| Assessment Status | Assessment process complete |
| HTA ID | - |
| Drug | Sofosbuvir |
| Brand | Solvaldi® |
| Indication | In combination with other medicinal products for the treatment of Chronic Hepatitis C in adults. |
| Assessment Process | |
| Rapid review commissioned | 12/02/2014 |
| Rapid review completed | 10/03/2014 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation Recommended |
| Full submission received from Applicant | 03/06/2014 |
| NCPE assessment outcome | Reimbursement Recommended for certain subgroups |